Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care--the Triumph project.
about
Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstructionBipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstructionBipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstructionThe Effect of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) on Erectile Function: A Systematic Review and Meta-AnalysisTadalafil for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a review of clinical data in Asian men and an update on the mechanism of actionCombination of tadalafil and finasteride for improving the symptoms of benign prostatic hyperplasia: critical appraisal and patient focusCustom 4-Plex DiLeu Isobaric Labels Enable Relative Quantification of Urinary Proteins in Men with Lower Urinary Tract Symptoms (LUTS)Tadalafil 5 mg once daily for the treatment of Asian men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: analyses of data pooled from three randomized, double-blind, placebo-controlled studies.Epidemiology of lower urinary tract symptoms: emphasis on the status in Korea.Obesity-induced diabetes and lower urinary tract fibrosis promote urinary voiding dysfunction in a mouse modelTargeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT studySystematic review of surgical treatments for benign prostatic hyperplasia and presentation of an approach to investigate therapeutic equivalence (non-inferiority).Bipolar transurethral resection versus monopolar transurethral resection for benign prostatic hypertrophy: a systematic review and meta-analysis.Symptomatic diagnosis of prostate cancer in primary care: a structured review.The prevalence of lower urinary tract symptoms in korean men aged 40 years or older: a population-based survey.CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis.Dutasteride plus tamsulosin fixed-dose combination first-line therapy versus tamsulosin monotherapy in the treatment of benign prostatic hyperplasia: a budget impact analysis in the Greek healthcare setting.The role of intraprostatic inflammation in the acute urinary retentionSystematic review and meta-analysis of Transurethral Needle Ablation in symptomatic Benign Prostatic Hyperplasia.In a free healthcare system, why do men not consult for lower urinary tract symptoms (LUTS)?Chemokines and BPH/LUTSManagement of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia by general practitioners in JakartaSystematic review and meta-analysis of candidate gene association studies of lower urinary tract symptoms in men.Prostate kallikrein markers in diagnosis, risk stratification and prognosis.Efficacy and safety of botulinum toxin injection for benign prostatic hyperplasia: a systematic review and meta-analysis.Application of two micron laser vaporesection combined with transurethral resection of the prostate in treatment of benign prostatic hyperplasia: analysis of 340 cases.Selecting therapy for maintaining sexual function in patients with benign prostatic hyperplasia.Incidence and progression of lower urinary tract symptoms in a large prospective cohort of United States menThe inflammatory microenvironment of the aging prostate facilitates cellular proliferation and hypertrophyUse of the SF-36 quality of life scale to assess the effect of pelvic floor muscle exercise on aging males who received transurethral prostate surgery.Erectile dysfunction and lower urinary tract symptoms: a consensus on the importance of co-diagnosis.Tamsulosin MR and OCAS (modified release and oral controlled absorption system): current therapeutic uses.Non-neural phenotype of spinal and bulbar muscular atrophy: results from a large cohort of Italian patients.Development of an Improved Animal Model of Overactive Bladder: Transperineal Ligation versus Transperitoneal Ligation in Male Rats.Spectrum of prostatic lesions.Nationwide incidence and treatment pattern of benign prostatic hyperplasia in Korea.Cost analysis of fixed-dose combination of dutasteride and tamsulosin compared with concomitant dutasteride and tamsulosin monotherapy in patients with benign prostatic hyperplasia in Canada.Factors related to receipt of non-cancer-related transurethral prostatectomy: findings from a large prospective study of 106 769 middle-aged and older Australian menImpact Assessment of Urethral Meatus Morphology and Penile Biometry in Transurethral Prostate and Bladder Surgery.Is diabetes mellitus associated with clinical outcomes in aging males treated with transurethral resection of prostate for bladder outlet obstruction: implications from Taiwan Nationwide Population-Based Cohort Study
P2860
Q24201329-EB4BF625-3ADF-4505-9FAE-1D5813FA2F4EQ24202297-4DE115D6-3D51-4076-965F-CB43EB6FFDB9Q24203775-00037859-0438-4C55-8A3F-0880EEDDAA7AQ26778205-FA589A6A-0A86-4EED-B5CC-8AA314438E5AQ26783529-139F9AC0-E6F9-42F9-AE22-6918101B2A8EQ27008847-B6CA10EA-C574-44C9-9517-FC0BB5C2D9E3Q28547212-EF5A984D-46AC-49C9-85E8-3447142363DAQ30899027-6ADA8F40-7001-4517-A86A-9D3E47635AEFQ33633711-52E7E1EA-385A-4ABE-899D-B2F4C3820E89Q33908275-0C3F05A4-1081-4463-8BF3-D5B49A731C9BQ33927384-D5760245-FDA2-412B-A37C-FA4693777689Q34007652-C4847F51-8356-457D-8F7C-302E341524E1Q34097164-390918B5-BD60-4323-AA62-F2392DD91212Q34247769-9466219B-FA0A-4486-AA43-5014FED35BC4Q34267495-D16F3D7D-765E-4AE4-B376-C31B4D9DF3D5Q34485215-88D6307E-C868-4154-B968-B932BD0D0812Q34539001-80079F37-1169-419D-91AB-47AFF502C834Q34714167-F6EF6611-2DEC-4B67-8C44-5AD37F0C0237Q34973367-FBCB946F-2793-4B8B-905F-1D5C149E97DBQ35085419-DD23AB27-21B7-4839-9F0C-B8AC4735374BQ35179438-8E5B5EA0-D4C2-4FAC-BD46-04DFAAE1D7E1Q35207995-F0E2AD4A-AD3B-49C8-9C66-FCBDDE3BE752Q35540054-70ECBB55-DB67-40E2-99E3-F4C870985F14Q35683035-22DE67F3-2CF6-4CC4-9BC4-82DC1939F764Q35839133-811F0260-49BB-4ADC-A7E7-2B5586BA0A17Q35894917-A3634979-EEA3-48AD-8D4F-7996B5DBF019Q36206605-49AAC345-56D6-44BE-97A1-D83FC1E03336Q36279542-CE8EBE49-44AE-46A5-81D1-5D883828D7E6Q36882164-0AD36B66-C0E8-4362-B173-73A788944B37Q36922163-4735ACB6-ED1B-43D5-9535-6FB8AABCFA59Q37108885-F3F3E058-000A-4877-9503-48BC904C8D07Q37111860-B5C2E51B-1E18-4667-8B59-12B36ED03A5AQ37156314-EBC7B4AB-165B-4DA5-BDB3-565F124C373CQ37208238-B920BDB6-C420-4872-9B53-768CE3DD8D3BQ37362008-A26C7EF1-8A7A-4760-B270-8E60DDCBDC3DQ37414781-59292B3A-E5DC-4D00-B03F-1D6B60E58CAAQ37496437-59DD2C6B-B2DE-432F-9729-D60B857B4521Q37639947-6AED04B0-3273-4C09-88AB-DC5A24B2AE02Q37680933-DC93BBED-815E-4563-9F8D-D2959580D92AQ37714109-FAE31794-533A-483A-AB23-284D415BC74A
P2860
Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care--the Triumph project.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Incidence and prevalence of lo ...... ary care--the Triumph project.
@ast
Incidence and prevalence of lo ...... ary care--the Triumph project.
@en
type
label
Incidence and prevalence of lo ...... ary care--the Triumph project.
@ast
Incidence and prevalence of lo ...... ary care--the Triumph project.
@en
prefLabel
Incidence and prevalence of lo ...... ary care--the Triumph project.
@ast
Incidence and prevalence of lo ...... ary care--the Triumph project.
@en
P2093
P1433
P1476
Incidence and prevalence of lo ...... ary care--the Triumph project.
@en
P2093
A Borkowski
A Costello
C P van Schayck
C R Chappel
F F H Rutten
F Jiménez Cruz
G S Bleumink
G Vallencien
P304
P356
10.1016/S0302-2838(02)00354-8
P407
P577
2002-10-01T00:00:00Z